FISH-aimed karyotype analysis in Aconitum subgen : aconitum reveals excessive rDNA sites in tetraploid taxa

The location of 5S and 35S rDNA sequences in chromosomes of four Aconitum subsp. Aconitum species was analyzed after fluorescence in situ hybridization (FISH). Both in diploids (2n = 2x = 16; Aconitum variegatum, A. degenii) and tetraploids (2n = 4× = 32; A. firmum, A. plicatum), rDNA repeats were localized exclusively on the shorter arms of chromosomes, in subterminal or pericentromeric sites. All analyzed species showed similar basal genome size (Cx = 5.31-5.71 pg). The most striking features of tetraploid karyotypes were the conservation of diploid rDNA loci and emergence of many additional 5S rDNA clusters. Chromosomal distribution of excessive ribosomal sites suggests their role in the secondary diploidization of tetraploid karyotypes

Assessment of threatened status, phytochemical composition and biological properties of three Aconitum species from Kashmir Himalaya - India

Genus Aconitum (Ranunculaceae) is represented by 6–8 species from Kashmir Himalaya.  Traditionally Aconitum species are used to treat a wide array of diseases, but their ethnopharmacological validation and phytochemistry are hitherto unreported from Kashmir Himalaya. The present study was undertaken to bring insights into the traditional use and distribution pattern of three Aconitum species from the region. An ethnobotany-directed approach was employed to study the conservation status of three Aconitum species. Their phytochemical profiles and biological properties were screened under in vitro conditions. Folin–ciocalteu and Aluminium chloride assays were employed to measure their total phenolic and total flavonoid contents, respectively. Plant extracts were evaluated for antioxidant, antimicrobial and anti-inflammatory activities. Three Aconitum species, viz. Aconitum heterophyllum Wall. ex Royle, Aconitum violaceum Jacquem. ex Stapf and Aconitum chasmanthum Stapf. ex Holmes showed dwindling conservation status in Kashmir Himalaya. Aconitum extracts showed significant variations in total phenolic and flavonoid contents. Antioxidant activity of Aconitum chasmanthum methanolic extract was studied to be comparatively higher (80.115%). Aconitum chasmanthum DCM & methanolic extracts showed a good MIC value of 0.125 mg/ml against Candida albicans and Streptococus pyogenes, respectively. The percent inhibition of NLRP inflammasome was found significant in Aconitum violaceum ethyl acetate extract (74.61%). The present study revealed that Aconitum species are constantly declining at least in investigated habitats of Kashmir Himalaya and hence need strategic conservation planning. The results also emphasized the utility of Aconitum species as an antioxidant, antimicrobial and anti-inflammatory agent that could be used to manage various health problems

Callus culture production of Aconitum barbatum Patr. ex Pers. аs a source of biologically active substances

Aconitum barbatum Patr. ex Pers. is perennial plant from the Ranunculaceae Juss. family. It is well known and used in traditional Chinese, Tibetan and Mongolian medicine for the treatment of many diseases. Aconitum barbatum is a rare species. The callus culture was obtained from Aconitum barbatum Patr. ex Pers. which is a very rich source of biologically active substances. The optimal conditions for cultivation and chemical analysis were selected for this culture. Chemical analysis showed the presence of phenolic compounds in callus culture of Aconitum barbatum

Callus culture production of Aconitum barbatum Patr. ex Pers. аs a source of biologically active substances

Aconitum barbatum Patr. ex Pers. is perennial plant from the Ranunculaceae Juss. family. It is well known and used in traditional Chinese, Tibetan and Mongolian medicine for the treatment of many diseases. Aconitum barbatum is a rare species. The callus culture was obtained from Aconitum barbatum Patr. ex Pers. which is a very rich source of biologically active substances. The optimal conditions for cultivation and chemical analysis were selected for this culture. Chemical analysis showed the presence of phenolic compounds in callus culture of Aconitum barbatum

Typification of Zapałowicz's names in Aconitum section Aconitum

Hugo Zapałowicz described and named 27 taxa in Aconitum sect. Aconitum. Their names are typified here. Two of them (Aconitum berdaui, Aconitum bucovinense) are deemed correct for currently accepted species of the Carpathians, 24 are reduced to synonymy under five taxa, and for one no original material has been located. The correct place and exact date of their publication, which differs from those usually assumed, have been ascertained by bibliographic verification and the study of archival documents

Resurrection of the genus Staphisagria J. Hill, sister to all the other Delphinieae (Ranunculaceae)

Molecular sequence data show that the three species of Delphinium subg. Staphisagria (J. Hill) Peterm. form the sister clade to Aconitum L., Aconitella Spach, Consolida (DC.) S.F. Gray, and all remaining species of Delphinium L. To account for this finding we resurrect Staphisagria J. Hill (1756). Names in Staphisagria are available for two of the species. We here make the required new combination for the third species, Staphisagria picta (Willd.) F. Jabbour, provide a key to the species, and illustrate one of them

Octodrine: New Questions and Challenges in Sport Supplements

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).Background: Octodrine is the trade name for Dimethylhexylamine (DMHA), a central nervous stimulant that increases the uptake of dopamine and noradrenaline. Originally developed as a nasal decongestant in the 1950’s, it has recently been re-introduced on the market as a pre-workout and ‘fat-burner’ product but its use remains unregulated. Our work provides the first observational cross-sectional analytic study on Octodrine as a new drug trend and its associated harms after a gap spanning seven decades. Methods: A comprehensive multilingual assessment of literature, websites, drug fora and other online resources was carried out with no time restriction in English, German, Russian and Arabic. Keywords included Octodrine’s synonyms and chemical isomers. Results: Only five relevant publications emerged from the literature search, with most of the available data on body building websites and fora. Since 2015, Octodrine has been advertised online as “the next big thing” and “the god of stimulants,” with captivating marketing strategies directed at athletes and a wider cohort of users. Reported side-effects include hypertension, dyspnoea and hyperthermia. Conclusions: The uncontrolled use of Octodrine, its physiological and psychoactive effects raise serious health implications with possible impact on athletes and doping practices. This new phenomenon needs to be thoroughly studied and monitored.Peer reviewe

Two major groups of chloroplast DNA haplotypes in diploid and tetraploid Aconitum subgen : Aconitum (Ranunculaceae) in the Carpathians

Aconitum in Europe is represented by ca. 10% of the total number of species and the Carpathian Mts. are the center of the genus variability in the subcontinent. We studied the chloroplast DNA intergenic spacer trnL(UAG)-rpl32-ndhF (cpDNA) variability of the Aconitum subgen. Aconitum in the Carpathians: diploids (2n=16, sect. Cammarum), tetraploids (2n=32, sect. Aconitum) and triploids (2n=24, nothosect. Acomarum). Altogether 25 Aconitum accessions representing the whole taxonomic variability of the subgenus were sequenced and subjected to phylogenetic analyses. Both parsimony, Bayesian and character network analyses showed the two distinct types of the cpDNA chloroplast, one typical of the diploid and the second of the tetraploid groups. Some specimens had identical cpDNA sequences (haplotypes) and scattered across the whole mountain arch. In the sect. Aconitum 9 specimens shared one haplotype, while in the sect. Camarum one haplotype represents 4 accessions and the second –accessions. The diploids and tetraploids were diverged by 6 mutations, while the intrasectional variability amounted maximally to 3 polymorphisms. Taking into consideration different types of cpDNA haplotypes and ecological profiles of the sections (tetraploids – high-mountain species, diploids – species from forest montane belt) we speculate on the different and independent history of the sections in the Carpathians

Garuda 5 (khyung lnga): Ecologies of Potency and the Poison-Medicine Spectrum of Sowa Rigpa’s Renowned ‘Black Aconite’ Formula

This article focuses on ethnographic work conducted at the Men-Tsee-Khang (Dharamsala, India) on Garuda 5 (khyung lnga), a commonly prescribed Tibetan medical formula. This medicine’s efficacy as a painkiller and activity against infection and inflammation is largely due to a particularly powerful plant, known as ‘virulent poison’ (btsan dug) as well as ‘the great medicine’ (sman chen), and identified as a subset of Aconitum species. Its effects, however, are potentially dangerous or even deadly. How can these poisonous plants be used in medicine and, conversely, when does a medicine become a poison? How can ostensibly the same substance be both harmful and helpful? The explanation requires a more nuanced picture than mere dose dependency. Attending to the broader ‘ecologies of potency’ in which these substances are locally enmeshed, in line with Sienna Craig’s Efficacy and the Social Ecologies of Tibetan Medicine (2012), provides fertile ground to better understand the effects of Garuda 5 and how potency is developed and directed in practice. I aim to unpack the spectrum between sman (medicine) and dug (poison) in Sowa Rigpa by elucidating some of the multiple dimensions which determine the activity of Garuda 5 as it is formulated and prescribed in India. I thus embrace the full spectrum of potency— the ‘good’ and the ‘bad,’ the ‘wanted’ and the ‘unwanted’—without presuming the universal validity of biomedical notions of toxicity and side effects

Are homeopathics able to replace antibiotics in the therapy of bovine mastitis? A placebo controlled randomized double-blind trial

To evaluate the effects of homeopathics on clinical mastitis cows and herd udder health this investigation was conducted in a Brandenburg bio-dyn herd of about 300 cows in two phases using a randomized doubleblind control trial design. After the first part in July 2002 the results preliminarily were evaluated and then the whole concept due to unsatisfying results was adapted. In Phase 1 a number of 121 clinical mastitis cases with 137 affected quarters matched the including criteria, in Phase 2 the number was 126 cows with 148 quarters. These animals were allocated to a code number which classified the case to Verum (n=65 and n=60) or placebo group (n=56 and n=66). In case of clinical mastitis cows were treated either by the oral dilution contending the required combined homeopathics or placebo. Animals were treated twice a day for 5 to 14 days (Phase 2: 1 to 7 days) depending on development of disease. In case of therapy failure in Phase 1 all animals were treated by an not coded homeopathic preparation and in Phase 2 by antibiotics according to bacteriological findings. Milk samples (double samples) for bacteriological and cell count investigation were taken before treatment (M1), 4 to 5 weeks after treatment termination (M2) and 7 to 8 weeks after treatment termination (M3). To evaluate the herd situation additional samples were taken after calving and before dry off. Healing criteria on the cow level was the clinical cure without secondary therapy and release to production. On quarter level the cure was determined by bacterial findings (BCR) and additional by cytological findings. A quarter was determined as „completely cured“, if no bacteria were found AND the cell count was below 100.000/ml. To assess the reduction of antibiotics within the concept it was hypothetically assumed that the mastitis cows had an average milk yield of 20,5 kg per day, was treated under conventional conditions by antibiotics over 3 days with a mean withdrawal time of 5 days (organic conditions x2). Afterwards, these theoretical values were compared to the extrapolated antibiotics input within our concept. Results While there is no difference between the cows in phase 1, on quarter level the verum group showed a significant higher complete cure rate than placebo group in Phase 2. These results are balanced by additional antibiotics treatment in case of therapy failure in the placebo group. The complete cure rate in the verum group after 8 weeks was 32% compared to 13% in placebo group (p<0.05). The limited cure results in single cows did not lead to an udder health depression of the herd. During the study the mean of somatic cell count could decreased by 100.000 cells/ml while the milk yield increased slightly by 250 kg/cow to 6.500 kg/cow/year. The number of actual antibiotic treatments during observation time compared to the number of mastitis cases which would be treated by antibiotics under conventionel conditions showed a reduction by 75%. The extrapolated reduction of milk loss by withdrawal was 25.000kg and the reduction of contaminated milk during treatment time was 13.100 kg per year for the herd. Discussion and Conclusions The increasing cure rates in the second part of the study are influenced by the enhancement of environmental preconditions in combination with the simplified therapy scheme. The therapists seemed to be more familiar with the fixed combinations of homeopathics so that positive effects of the homeopathics can be seen in this phase. After additional antibiotic treatments in case of therapy failure in specific infections (i.e. streptococci and staph. aureus) the cure rates could be elevated to a satisfying level. This fact shows that the limited and controlled use of antibiotics in organic herds can be helpful in the mastitis control. Regardless the conceptual modification to an antibiotic emergency concept, the massive reduction of antibiotics in combination with an increase of herd udder health justifies the therapy protocol in the second phase of the study. Hypothetically, the self cure of the animals is higher than known. The interaction between farmer or therapist and the cow could be a crucial criterion for the positive development of disease. As a conclusion, the integrated system consisting of preventive herd measures and complementary therapy added by limited antibiotic therapy. The precondition for the success is the attendance to optimize environmental conditions. The therapy system should be transparent, simple and easy to use. However, it is necessary to reflect every single mastitis case as a special one